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Cells are subjected to endogenous [e.g., reactive oxygen species (ROS), replication stress] 
and exogenous insults (e.g., UV light, ionizing radiation, and certain chemicals), which 
can affect the synthesis and/or stability of different macromolecules required for cell and 
tissue function. Oxidative stress, caused by excess ROS, and DNA damage, triggered in 
response to different sources, are countered and resolved by specific mechanisms, 
allowing the normal physiological equilibrium of cells and tissues to be restored. One 
process that is affected by oxidative stress and DNA damage is extracellular matrix (ECM) 
remodeling, which is a continuous and highly controlled mechanism that allows tissues 
to readjust in reaction to different challenges. The crosstalk between oxidative stress/DNA 
damage and ECM remodeling is not unidirectional. Quite on the contrary, mutations in 
ECM genes have a strong impact on tissue homeostasis and are characterized by 
increased oxidative stress and potentially also accumulation of DNA damage. In this 
review, we will discuss how oxidative stress and DNA damage affect the expression and 
deposition of ECM molecules and conversely how mutations in genes encoding ECM 
components trigger accumulation of oxidative stress and DNA damage. Both situations 
hamper the reestablishment of cell and tissue homeostasis, with negative impacts on 
tissue and organ function, which can be a driver for severe pathological conditions.
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INTRODUCTION
Redox reactions are central to ensure correct cell function, allowing a dynamic transfer of 
electrons across different molecules (McCord, 2000). This occurs, for example, during molecular 
oxygen metabolism in the mitochondria, which are the central metabolic machinery of cells. 
Molecular oxygen metabolism is the basis of oxidative phosphorylation, and promotes the 
production of reactive oxygen species (ROS) (Sabharwal and Schumacker, 2014; Shadel and 
Horvath, 2015). ROS also play an important role in immune defenses, where innate immune 
cells produce ROS as part of their pathogen killing strategies (Khan et  al., 2018). In fact, 
neutrophils and some macrophages express myeloperoxidase (MPO), which leads to the generation 
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of different ROS, including hypochlorous acid (HOCl), a potent 
ROS that is involved in pathogen killing mechanisms 
(Khan et  al., 2018).
However, when in excess, ROS may cause serious damage 
to different molecules promoting DNA damage, protein oxidation, 
and lipid peroxidation (McCord, 2000). The deleterious 
accumulation of ROS may have multiple origins, including 
the excessive ROS production by the mitochondria, which 
drives mitochondrial dysfunction, an important trait of a variety 
of diseases. Mitochondrial dysfunction can be due to a metabolic 
imbalance (Bhatti et  al., 2017), like, for example, in diabetes, 
where high levels of glucose promote overproduction of ROS 
(Yaribeygi et  al., 2019), or it may also arise as a consequence 
of mutations in mitochondrial DNA, defective OXPHOS, and 
alterations in ROS production, which are common phenomena 
in cancer (Hsu et al., 2016; Porporato et al., 2018). As mentioned 
above, another example of excess ROS generation is through 
MPO in neutrophils, which can have a detrimental outcome 
if it leads to chronic inflammation, a driver of pathology in 
a variety of diseases (Khan et  al., 2018).
DNA damage can be  caused by several factors, including 
by exogenous agents, e.g., UV light, ionizing radiation, as well 
as by endogenous triggers, such as errors in DNA replication 
and oxidative stress. DNA replication is a central process during 
cell division, where accuracy is essential to maintain the genetic 
information intact (Sancar et  al., 2004; Zeman and Cimprich, 
2014). However, DNA replication can also be  a source of 
deleterious events leading to DNA damage, in particular, due 
to aberrant replication fork structures such as breaks associated 
with replication fork stalling and collapse (Zeman and Cimprich, 
2014). Oxidative stress is also an important source of DNA 
damage (Whitaker et  al., 2017), since increased levels of ROS 
can result in DNA oxidation, particularly in oxidized DNA 
bases. Depending on the source of DNA damage, a specific 
machinery is activated to promote successful repair (Sancar 
et  al., 2004; Zeman and Cimprich, 2014). When DNA damage 
cannot be  repaired, cells may undergo programmed cell death 
or accumulate mutations that drive genomic instability, which 
can be a trigger for tumorigenesis (Hanahan and Weinberg, 2011).
Even though, dedicated machineries exist to cope with both 
oxidative stress and DNA damage, when these insults occur, 
they often lead to a variety of cellular and extracellular changes, 
which are important to ensure that cells return to their normal 
physiological equilibrium. One of these changes is extracellular 
matrix (ECM) remodeling. The ECM provides support to tissues 
and contributes to maintain their appropriate physiological 
environment (Frantz et  al., 2010; Bonnans et  al., 2014). It 
consists of a network of extracellular glycoproteins (e.g., collagens, 
fibronectin, and laminins), elastins, proteoglycans, hyaluronan, 
and a number of other less well characterized ECM components, 
collectively termed matrisome (Hynes and Naba, 2012; Naba 
et  al., 2016; Figure  1A). ECM components can be  directly 
linked to the cell surface and the underlying cytoskeleton, 
allowing a rapid and precise communication between the cells 
and the ECM. The communication between the extracellular 
and intracellular environments is mediated by transmembrane 
proteins, such as integrins, syndecans, and dystroglycan 
(Moore and Winder, 2012; Afratis et  al., 2017; Bachmann 
et  al., 2019). These transmembrane proteins bind directly to 
specific domains of ECM molecules on the extracellular side, 
and to cytoskeletal proteins and different kinases on the 
intracellular side, thus allowing the transmission of signaling 
cascades. In addition, the ECM can also act as a route or 
reservoir for different molecules with important autocrine and 
paracrine functions that include cytokines, chemokines, and 
growth factors, which modulate a variety of different cellular 
processes, such as cell adhesion, migration, differentiation, 
proliferation, survival, and apoptosis (Bowers et  al., 2010; 
Bonnans et  al., 2014).
Extracellular matrix remodeling is a normal process that 
occurs during embryonic development, allowing the progressive 
formation of tissues and organs, and continues throughout 
adulthood in order to ensure the balance of organismal 
homeostasis (Rozario and DeSimone, 2010; Bonnans et  al., 
2014). It is also an important player in tissue healing and 
repair but, when not properly regulated, it can result in the 
loss of normal tissue structure and the development of different 
pathological conditions. Examples of such conditions are (i) 
fibrosis, where extensive ECM deposition and scar formation 
hamper normal tissue and organ function (Herrera et al., 2018; 
Li et al., 2018), (ii) diabetes, where ECM remodeling is negatively 
affected in several aspects of the disease, including in the 
impaired healing of chronic diabetic wounds and in diabetes-
associated fibrosis (Falanga, 2005; Law et  al., 2012; Ahmad 
et al., 2020), and (iii) cancer, where several components involved 
in ECM remodeling have their specific functions hijacked by 
cancer cells, enabling their proliferation, epithelial-to-
mesenchymal transition, and migration (Bonnans et  al., 2014; 
Winkler et  al., 2020). Interestingly, diseases characterized by 
extensive ECM remodeling often involve oxidative stress and 
DNA damage, either as the triggers or as a consequence of 
their pathophysiology. This is the case of the aforementioned 
pathologies: fibrosis, a pathological condition marked by high 
levels of oxidative stress and a direct implication of DNA 
damage (Cheresh et  al., 2013; Li et  al., 2018); diabetes, which 
is associated with high levels of blood glucose that in turn 
lead to increased ROS levels (Yaribeygi et al., 2019); and cancer 
in which both DNA damage and oxidative stress play an 
important role in disease progression (Luo et  al., 2009; Reuter 
et al., 2010; Hanahan and Weinberg, 2011). On the other hand, 
several diseases due to mutations in ECM components or 
proteins linking the ECM to the cell cytoskeleton have been 
shown to display increased oxidative stress and DNA damage 
in the affected tissues (Rando, 2002; Irwin et al., 2003; Rodriguez 
and Tarnopolsky, 2003; Millay et  al., 2008; Shkryl et  al., 2009; 
Menazza et  al., 2010; de Oliveira et  al., 2014; Sorato et  al., 
2014; Fontes-Oliveira et  al., 2017; Gremminger et  al., 2019; 
Kölbel et  al., 2019; Moore et  al., 2020). This is particularly 
striking when considering the muscular dystrophies, but other 
examples also exist.
It is essential to point out that ECM remodeling does not 
only involve the synthesis and deposition of ECM molecules, 
which transmit signals to cells through cell surface receptors. 
The action of specific proteins that degrade ECM components, 
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FIGURE 1 | Extracellular matrix (ECM) remodeling upon oxidative stress and DNA damage. (A) The ECM is composed of various molecules, such as extracellular 
glycoproteins (e.g., collagens, fibronectin, and laminins), elastins, proteoglycans, and hyaluronan. These components are in close communication with the cell via 
transmembrane proteins (e.g., integrins, syndecans, and dystroglycan) that anchor different ECM components to the cell, activating various signal transduction 
cascades. Specific tissues have specialized ECMs and cell surface receptors, as can be observed for skeletal muscle, where the dystrophin-glycoprotein complex 
anchors laminins and links them to the actin cytoskeleton via dystrophin. ECM remodeling is carried out through the action of metalloproteinases (MMPs) and 
(Continued)
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including metalloproteinases (MMPs), and enzymes that shape 
ECM structure, such as lysyl oxidase (LOX), also play a crucial 
role (Bonnans et al., 2014; Shimoda and Khokha, 2017; Laczko 
and Csiszar, 2020; Figure 1A). Indeed, the importance of MMPs 
and their inhibitors, tissue inhibitors of metalloproteinases 
(TIMPs), in the response to oxidative stress and DNA damage 
has been extensively addressed elsewhere (Mehta et  al., 2006; 
Kandasamy et al., 2010; Reuter et al., 2010; Sanchez-Valle et al., 
2012; Broustas and Lieberman, 2014; Kumari et  al., 2018) and 
are beyond the scope of this review.
Considering the body of work showing the deleterious effects 
of oxidative stress and DNA damage in the context of a variety 
of diseases on the one hand, and on the other hand, the 
impact of changes in the ECM for disease onset and progression, 
this review aims to examine the potential links between oxidative 
stress/DNA damage and the ECM in the context of disease 
development. We  explore studies showing how oxidative stress 
and DNA damage affect the synthesis of ECM molecules, 
focusing on the major, and best studied, glycoproteins of the 
ECM, namely collagens, fibronectin, and laminins (Hynes and 
Naba, 2012; Naba et  al., 2016). We  also examine the inverse 
situation, where mutations in genes encoding some of these 
key ECM glycoproteins or proteins that link the ECM to the 
cell cytoskeleton trigger an accumulation of oxidative stress 
and DNA damage. This dual approach aims to address to 
what extent oxidative stress and DNA damage are part of the 
molecular processes that control, and are controlled by, the 
ECM, and through this perspective, we  may deepen our 
understanding of how they contribute to disease development 
and progression.
THE IMPACT OF OXIDATIVE STRESS 
ON ECM REMODELING
Analysis of NCBI Gene Expression Omnibus database for stress 
responses in HeLa cells showed that several different forms 
of stress, including oxidative stress, lead to changes in the 
expression of genes encoding structural and signaling components 
of the ECM (Chovatiya and Medzhitov, 2014). Here, we review 
the literature reporting when oxidative stress affects the synthesis 
or structure of the best studied ECM glycoproteins, namely 
collagens, fibronectin, and laminins.
Several studies have shown that the synthesis and/or the stability 
of several collagens, including collagen I, the most abundant 
fibrous protein of the ECM, are regulated by oxidative stress 
(Figure  1B). However, the exact role played by oxidative stress 
in the regulation of collagen synthesis is still not fully understood, 
and apparent contradictory results have been described. Siwik 
et  al. (2001) showed that oxidative stress can inhibit collagen 
I  and IV mRNA expression, while other studies have shown that 
oxidative stress can also lead to increased collagen expression 
(Iglesias-De La Cruz et  al., 2001; Zhao et  al., 2008; Guo et  al., 
2018; Kazakov et  al., 2018). This apparent discrepancy might 
be  explained by the amount of oxidative stress in the tissue, as 
suggested by Liu et  al. (2016). In this work, human uterosacral 
ligament-derived fibroblasts were treated with a low concentration 
of H2O2, an important ROS, which led to a decrease in COL1A1 
(gene codifying for collagen type I  α1 chain) expression. In 
contrast, when these cells were exposed to a higher concentration 
of H2O2, their COL1A1 expression increased (Liu et  al., 2016). 
This suggests that mild oxidative stress, associated with normal 
metabolism or small insults, may promote the reduction of collagen 
levels, whereas high levels of oxidative stress may favor collagen 
accumulation. Collagen deposition is required for wound healing, 
but if in excess, can also account for a tissue injury status like 
fibrosis. In support of this observation, several studies have shown 
that the presence of elevated levels of oxidative stress lead to 
increased collagen I  and III levels contributing to myocardial 
fibrosis (Zhao et  al., 2008; Sriramula and Francis, 2015; Kazakov 
et  al., 2018). In addition, treatment with antioxidants in the 
context of cardiac fibrosis has been shown to reduce collagen 
levels (Zhao et  al., 2008; Guo et  al., 2018), further suggesting a 
direct effect between increased oxidative stress and collagen 
deposition. Glucose deregulation is another mechanism known 
to cause oxidative stress, as observed for diabetes (Yaribeygi et al., 
2019). Kidney glomerular mesangial cells cultured with high levels 
of glucose show increased collagen IV synthesis (Ayo et al., 1991). 
Moreover, the synthesis of collagen I  and III is increased in 
hearts of experimental diabetic rats, a condition that was countered 
by antioxidant treatment (Guo et  al., 2018). The regulation of 
collagen synthesis by ROS may not only occur at the transcriptional 
level. It is well established that the antioxidant vitamin C is a 
cofactor of prolyl hydroxylase and lysyl hydroxylase, required for 
post translational modifications of procollagen and consequently 
in the correct formation of the mature collagen triple helix (Frantz 
et al., 2010; Bonnans et al., 2014). To corroborate the relationship 
between collagen levels and oxidative stress, it has recently been 
suggested that vitamin C, due to its role as an antioxidant, could 
improve healing associated with musculoskeletal diseases, by 
reducing the levels of ROS associated with the inflammatory 
response (DePhillipo et al., 2018). Even though, pre-clinical studies 
FIGURE 1 | lysyl oxidase (LOX). (B) ECM remodeling can be promoted by oxidative stress. In the presence of increased reactive oxygen species (ROS) levels [e.g., 
diabetes, high H2O2, hypochlorous acid (HOCl), or HOCl-modified fibronectin], some ECM genes become more highly expressed, such as fibronectin (FN1), collagen 
α1 chain (COL1A1), and laminin α1 chain (LAMA1), while others show decreased expression, as observed for laminin β2 chain (LAMB2). The exact mechanism(s) by 
which oxidative stress induces expression of ECM genes remains to be fully uncovered. The role of oxidative stress is also revealed by treatment with antioxidants 
where reduction in the levels of ROS normalizes ECM composition. (C) DNA damage (represented as a yellow electric ray symbol on top of double stranded DNA) is 
another insult that triggers changes in the ECM. The DNA damage responsive protein p53 has been implicated in the downregulation of FN1 expression, promoting 
cell motility and suppressing apoptosis. Another important player in this context is p21. This negative regulator of the cell cycle has been shown to induce COL1A1 
expression and consequently lead to collagen deposition and fibrosis. The transcription factor p73, a p53 family member, is also a key protein in ECM remodeling in 
the response to DNA damage. Upon activation, p73 has been demonstrated to directly promote the transcription of ITGB4, encoding integrin β4, and consequently 
promoting cell adhesion. For simplicity, not all ECM components are shown in the figures, just the ones that are relevant to illustrate the phenomenon being 
highlighted.
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have shown that vitamin C can reduce ROS and promote tissue 
healing via collagen I  synthesis during bone fracture recovery 
and in ruptured tendons, more studies in a clinical setting are 
needed to assess its therapeutic benefit (DePhillipo et  al., 2018).
The expression or stability of fibronectin has also been linked 
to oxidative stress. Fibronectin (FN1) expression has been shown 
to be  positively regulated in the presence of different sources of 
oxidative stress (Iglesias-De La Cruz et  al., 2001; Siwik et  al., 
2001; Lee et  al., 2004; Nybo et  al., 2018; Figure  1B). Oxidative 
stress, due to high glucose levels, increases the expression of 
FN1 in  vitro (Ayo et  al., 1991; Lee et  al., 2004; Lin et  al., 2006), 
as well as in vivo, in the context of diabetes (Lin et  al., 2006). 
ROS reduction by treatment with the ROS scavenging enzyme 
superoxide dismutase (SOD) led to a reduction in fibronectin 
levels in diabetic rats and to less kidney damage (Lin et  al., 
2006). Furthermore, HOCl generated through MPO activity in 
neutrophils has been shown to induce fibronectin modifications, 
such as tyrosine chlorination and dichlorination and oxidation 
of different residues, which reduced cell adhesion and increased 
proliferation of human coronary artery smooth muscle cells in 
vitro (Nybo et  al., 2018). The HOCl-induced modifications of 
fibronectin also led to changes in the expression of ECM genes 
by these smooth muscle cells, including a significant upregulation 
of FN1 and LAMA1 and downregulation of LAMB2 expression 
(Nybo et  al., 2018; Figure  1B). LAMA1 codifies the laminin α1 
chain, which is normally not present in the basement membrane 
of smooth muscle cells, while downregulation of LAMB2 codifying 
the laminin β2 chain indicates that cells are prevented from 
maintaining β2 laminins, characteristic of mature smooth muscle 
basement membranes (Yousif et  al., 2013). These data indicate 
that cells attempt to remodel their ECM in response to their 
oxidant-altered fibronectin substrate and associated effects on cell 
adhesion and proliferation.
Altogether, these various studies show that oxidative stress 
causes changes in both ECM gene expression and in ECM 
structure which correlate with tissue damage.
THE IMPACT OF DNA DAMAGE ON 
ECM REMODELING
It is well established that DNA integrity is essential for gene 
expression and for the correct transmission of genetic information 
to daughter cells during mitosis. It is not surprising that DNA 
damage is one of the most deleterious forms of injury inflicted 
on cells (Sancar et  al., 2004; Branzei and Foiani, 2008). Here, 
we  will consider how DNA damage, independently of the 
source (e.g., ROS, radiation, and mutagens), can directly or 
indirectly affect the expression of genes encoding either ECM 
glycoproteins or proteins linking the ECM to the cell cytoskeleton.
A central protein involved in the DNA damage response is 
the tumor suppressor p53, which, when activated, either induces 
cell cycle arrest to allow for DNA repair or, if the damage inflicted 
is too large, promotes, for example, apoptosis (Sancar et  al., 2004; 
Branzei and Foiani, 2008; Williams and Schumacher, 2016). p53 
has been implicated in the regulation of FN1 expression. Depletion 
of p53 was shown to increase FN1 mRNA expression, leading 
to increased cell motility and decreased apoptosis (Yokoi et al., 2020; 
Figure  1C), while treatment with the p53 activator RITA caused 
a decrease in fibronectin levels (You et  al., 2017). These studies 
thus indicate p53 as a negative regulator of FN1 expression. In 
accordance with this notion, overexpression of wild type p53  in 
ovarian carcinoma cells was able to repress the activity of the 
FN1 promoter, while a mutant p53 failed to do so (Yokoi et  al., 
2020), showing that p53 can act as a transcription factor directly 
regulating FN1 transcription. Another indication of an effect of 
DNA damage on the expression of ECM components came from 
a study on the CDK inhibitor p21 (Yosef et  al., 2017), a negative 
regulator of the cell cycle, which can be  induced by p53 and 
drive cell cycle arrest (Williams and Schumacher, 2016). This study 
revealed that in p21 knockout mice, senescent cells were eliminated, 
and liver fibrosis was alleviated mainly via transcriptional 
downregulation of collagen type I α1 (COL1A1; Yosef et al., 2017; 
Figure  1C). In fact, p21 knockout reduced Col1a1 expression, 
prevented collagen deposition and consequently fibrosis, in mice 
treated with carbon tetrachloride, a fibrogenic agent known to 
cause DNA damage (Yosef et al., 2017). These observations suggest 
that one of the actions of p21 is to increase COL1A1 expression 
in response to DNA damage. However, further studies are needed 
to assess whether these described effects of p53 and p21 on FN1 
and COL1A1 expression, respectively, are cell type specific and 
exactly how the pathways involved control cell survival, senescence, 
and apoptosis.
Integrins provide yet another link between ECM structure 
and DNA damage-induced apoptosis (Hoyt et  al., 1996; Sethi 
et al., 1999; Hodkinson et al., 2006; Jinushi et al., 2012; Ahmed 
et  al., 2018; Kowalski-Chauvel et  al., 2018; Hou et  al., 2019; 
Jung et al., 2019; Naci et al., 2019; Li et al., 2021). Nevertheless, 
the connection between adhesion and apoptosis is not linear 
and integrin binding to the ECM can either promote or prevent 
cells, in particular cancer cells, from undergoing apoptosis. It 
is possible that regulation mediated by factors involved in the 
DNA damage response, such as p53 and p21, control the 
expression of integrins or ECM components and therefore 
modulate adhesion. Indeed, it has been shown that p73, a 
p53 family member that can also be  activated in response to 
DNA damage, directly promotes transcription of ITGB4, encoding 
integrin β4, therefore acting as a positive regulator of cell 
adhesion (Xie et  al., 2018; Figure  1C).
Collectively, this suggests that central DNA damage response 
factors might be  able to directly control the expression of 
ECM components and integrins, hence being able to regulate 
cell survival and apoptosis.
MUTATIONS IN GENES ENCODING ECM 
COMPONENTS TRIGGER OXIDATIVE 
STRESS AND DNA DAMAGE
As discussed above, the notion that oxidative stress and DNA 
damage result in alterations in the ECM in the context of different 
diseases has been gaining ground. However, does the inverse 
occur? Does a dysfunctional ECM induce oxidative stress and 
DNA damage in the cells it harbors? Indeed, some observations 
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suggest that this is the case. For example, culture of human 
dermal fibroblasts in fragmented collagen matrices, resulted in 
elevated levels of ROS in these cells compared to fibroblasts 
cultured in intact collagen matrices (Fisher et  al., 2009). Here, 
we  explore the literature on diseases caused by mutations in 
genes encoding ECM components and proteins that link the 
ECM to the cytoskeleton, more specifically collagens, laminin 
211, and dystrophin, to assess whether they are linked to oxidative 
stress and/or DNA damage.
Collagen Deficiency
Collagen I  is present in a variety of connective tissues (Frantz 
et  al., 2010; Bonnans et  al., 2014). Mutations in COL1A1 and 
COL1A2 genes, encoding the α1 and α2 chains of collagen I, 
respectively, cause osteogenesis imperfecta, a disease characterized 
by brittle bones, short stature, and muscle weakness (van Dijk 
et  al., 2011; Marini et  al., 2017). Recently, a study using the 
mouse model of osteogenesis imperfecta, the Col1a2oim mouse, 
also known as oim/oim mouse, revealed that the muscles of mice 
homozygous for the mutation display a mitochondrial dysfunction 
in that they have decreased levels of electron transport chain 
complex IV, mitochondrial encoded cytochrome oxidase I, energy 
production, citrate synthase activity and respiration, and elevated 
levels of PGC1α (Gremminger et  al., 2019), all markers of 
mitochondrial dysfunction (Adhihetty et  al., 2009; Li et  al., 2020; 
Melouane et  al., 2020; Figure  2). These results suggest that 
mitochondrial dysfunction is an important feature of the muscles 
of oim/oim mice, but the exact mechanism that links collagen 
I deficiency to mitochondrial dysfunction remains to be determined. 
Moreover, excessive ROS production in the context of collagen 
I deficiency may also contribute to the exacerbation of osteogenesis 
imperfecta pathology in bone. Indeed, high ROS generation is 
associated with inhibition of new bone formation, suggesting that 
antioxidant treatment may be  useful to treat diseases with bone 
loss (Wauquier et  al., 2009).
Collagen VI is a type of collagen mainly found in muscles, 
tendons, and skin (Bönnemann, 2011). Mutations in the COL6A1, 
COL6A2, and COL6A3 genes, encoding chains of collagen VI, 
are associated with Ullrich congenital muscular dystrophy and 
Bethlem myopathy, a severe and mild form of collagen VI 
deficiency, respectively (Bönnemann, 2011; Bernardi and Bonaldo, 
2013). Collagen VI deficiency has also been correlated with 
oxidative stress. Studies using a mouse model of collagen VI 
deficiency, Col6a1−/− mice, revealed elevated levels of ROS, 
mitochondrial dysfunction and elevated levels of monoamine 
oxidase A (MAO-A) (Irwin et  al., 2003; Menazza et  al., 2010; 
Sorato et  al., 2014; Figure  2), one of the major contributors to 
ROS production in the mitochondria (Canton et al., 2014). After 
treatment with MAO inhibitor, muscles from Col6a1−/− mice 
showed a decrease in ROS levels when compared to untreated 
mice (Menazza et  al., 2010; Sorato et  al., 2014), highlighting 
the enhanced production of ROS by these enzymes when collagen 
VI is absent. Consistent with this, treatment with a MAO inhibitor 
(Menazza et  al., 2010; Sorato et  al., 2014) and treatment with 
a mitochondrial permeability transition pore inhibitor (Irwin 
et  al., 2003; Merlini et  al., 2008; Palma et  al., 2009), reduced 
the apoptotic phenotype and improved mitochondrial function 
in Col6a1−/− mice and patients with collagen VI deficiency. 
Altogether, these studies reinforce the idea that the absence of 
collagen VI drives excess ROS production in the mitochondria, 
potentially contributing to the observed muscle fiber damage.
LAMA2 Deficiency
The LAMA2 gene encodes the laminin α2 chain of laminin 
211. Mutations in LAMA2 lead to a congenital muscular dystrophy 
(LAMA2-CMD; also known as merosin-deficient congenital 
muscular dystrophy type 1A, MDC1A) which is characterized 
by muscle weakness, fibrosis, and chronic inflammation (Gawlik 
and Durbeej, 2011; Yurchenco et  al., 2018). Recently, different 
mouse models of LAMA2-CMD (the dy2J/dy2J and dy3K/dy3K 
mouse models) and biopsies from LAMA2-CMD patients were 
used to address the impact of oxidative stress on this condition 
(de Oliveira et  al., 2014; Fontes-Oliveira et  al., 2017; Gawlik 
et  al., 2019; Kölbel et  al., 2019; Harandi et  al., 2020). These 
studies indicate that the muscles of Lama2-deficient mice and 
LAMA2-CMD patients display an increase in oxidative stress 
both in early and more advanced stages of the disease, pointing 
to an important role of oxidative stress throughout disease 
progression (Gawlik et  al., 2019; Harandi et  al., 2020). In fact, 
dy3K/dy3K mice show high levels of oxidative stress in quadriceps 
at least from post-natal day 7 and increased Gclm and Sqstm1 
expression, markers of oxidative stress, at post-natal day 21 
(Gawlik et  al., 2019). Analysis of muscles from 3-week-old dy2J/
dy2J mice and muscle biopsies from LAMA2-CMD patients (age 
ranging between 22  days and 29  years) also confirmed the 
presence of elevated levels of ROS in both cases (Harandi et  al., 
2020). Moreover, the treatment of dy2J/dy2J mouse quadriceps 
and triceps muscles with the antioxidant N-acetylcysteine (NAC) 
partially rescued the motor function of dy2J/dy2J mice, reduced 
the number of apoptotic fibers, lowered the levels of inflammation 
markers and prevented fibrosis (Harandi et  al., 2020). Vitamin 
E, another antioxidant, applied to the same mouse model reduced 
the number of apoptotic fibers and attenuated inflammation in 
quadriceps muscles, although, it did not improve motor function 
or reduce fibrosis (Harandi et  al., 2020). Nevertheless, both 
antioxidants were able to improve dy2J/dy2J skeletal muscle 
morphology, in particular, by normalizing the proportion of 
small fibers, decreasing the number of fibers with centrally located 
nuclei, and decreasing ROS production (Harandi et  al., 2020).
Mitochondrial dysfunction, closely associated with elevated 
oxidative stress, also plays a central role in LAMA2-CMD 
pathology. In fact, it was observed that Lama2-deficient mice 
present signs of mitochondrial swollenness (Millay et al., 2008) 
and downregulation of a variety of mitochondria specific genes 
encoding components of the electron transport chain/oxidative 
phosphorylation (de Oliveira et al., 2014; Fontes-Oliveira et al., 
2017; Figure 2). Likewise, muscles or muscle-derived cells from 
LAMA2-CMD patients were described as having an abnormal 
membrane potential (Fontes-Oliveira et  al., 2017), impaired 
mitochondrial function and bioenergetic status and 
downregulation of a variety of mitochondrial related genes 
(Fontes-Oliveira et  al., 2017; Kölbel et  al., 2019). Altogether, 
these results support the hypothesis that oxidative stress and 
mitochondrial dysfunction are hallmarks of LAMA2-CMD.
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Dystrophin Mutations
Dystrophin is part of the dystrophin-glycoprotein complex which 
links cytoplasmic dystrophin to laminin 211  in the muscle fiber 
basement membrane, a link that is responsible for conferring 
cellular stability during skeletal muscle contractions (Ervasti and 
Campbell, 1993). Mutations in the DMD gene, encoding dystrophin, 
can cause Duchenne muscular dystrophy (DMD), characterized 
by muscle weakness, inflammation, and fibrosis (Grounds et  al., 
2020). Several mechanisms are known to contribute to DMD 
pathology, including oxidative stress (Rando, 2002; Grounds et al., 
2020). Early studies of the disease showed that DMD muscles 
display oxidative stress features, such as increased lipid peroxidation 
(Hunter and Mohamed, 1986) and increased levels of oxidative 
stress responsive enzymes (Austin et  al., 1992). Moreover, in vivo 
and in vitro analyzes of mdx mice, the most widely used DMD 
model, showed an increased susceptibility to muscle injury caused 
by free radicals (Disatnik et al., 1998; Rando et al., 1998), suggesting 
a deficiency in oxidative stress responses in mdx mice. During 
the last decades, the oxidative stress hypothesis has been gathering 
support with several studies showing high levels of ROS in muscles 
of mdx mice (Ragusa et  al., 1997; Williams and Allen, 2007; 
Segatto et  al., 2020) and DMD patients (Haycock et  al., 1997; 
Rodriguez and Tarnopolsky, 2003). The excessive production of 
ROS in DMD patients and mdx mice may have multiple sources, 
including activation of inflammatory cells (Whitehead et al., 2008; 
Grounds et  al., 2020), increased activity of NADPH oxidase 
(Williams and Allen, 2007; Whitehead et al., 2010), mitochondrial 
dysfunction (Shkryl et  al., 2009; Menazza et  al., 2010), and 
alterations in antioxidant pathways, including, for example, the 
elevated levels of oxidative stress sensor nuclear factor erythroid 
2-related factor 2 (Nrf2) (Petrillo et  al., 2017) and overactivation 
of the nuclear factor κB (NF-κB) pathway (Kumar and Boriek, 
2003; Monici et  al., 2003; Figure  2). Using antioxidizing drugs, 
such as vitamin C or SOD, and treatment with the antioxidant 
NAC reduced the levels of ROS in cardiac (Williams and Allen, 
2007) and skeletal muscles (Whitehead et al., 2008) of mdx mice. 
It also reduced the expression of markers of inflammation and 
fibrosis (Williams and Allen, 2007), as well as, the number of 
apoptotic fibers (Whitehead et  al., 2008). This observed rescue 
of the DMD phenotype using antioxidant treatments suggests a 
possible role of ROS in the inflammation, fibrosis, and apoptosis 
characteristic of DMD.
Elevated levels of NADPH oxidase and its regulator caveolin-3 
is also a hallmark of mdx muscles (Williams and Allen, 2007; 
Whitehead et  al., 2010; Petrillo et  al., 2017; Segatto et  al., 2020). 
NADPH oxidase produced in skeletal muscles fibers has been 
FIGURE 2 | Mutations in ECM components increase oxidative stress. Many diseases caused by mutations in ECM components or components that link ECM to 
the cytoskeleton have been associated with generation of excess ROS levels. The loss of collagen I, collagen VI, laminin α2, or dystrophin was shown to induce 
mitochondrial dysfunction, a major source of ROS. Additionally, high ROS levels due to either increased activity of monoamine oxidase A (MAO-A) or NADPH 
oxidase have also been associated with the loss of specific ECM or ECM-related components. Loss of laminin α2 or dystrophin leads to increased levels of ROS as 
a consequence of the activation of inflammatory cells. Dystrophin loss was also shown to promote changes in the activity of antioxidant pathways and ROS-induced 
DNA damage.
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shown to be  a major source of stretch-induced ROS in mdx 
mice (Shkryl et  al., 2009; Whitehead et  al., 2010), since it allows 
the generation of the free radical superoxide. Furthermore, NAC 
treatment reduced caveolin-3 expression and NF-κB activation 
in skeletal muscles from mdx mice (Whitehead et  al., 2008). 
Another important player in DMD pathology is mitochondrial 
dysfunction (Menazza et  al., 2010; Moore et  al., 2020). Elevated 
levels of MAO were reported in mdx mice (Menazza et al., 2010), 
as well as, reduced mitochondrial DNA copy number (Moore 
et  al., 2020). Inhibition of MAO reduced tropomyosin oxidation 
(an oxidation marker), normalized fiber size, and reduced tissue 
inflammation and apoptosis (Menazza et  al., 2010).
Reactive oxygen species pose various risks for the integrity 
of different macromolecules including DNA. In keeping with this 
notion, DMD patients present high levels of DNA damage associated 
with increased oxidative stress (Rodriguez and Tarnopolsky, 2003) 
and cells derived from DMD patients are more sensitive to 
DNA-damaging agents than control cells (Robbins et  al., 1984). 
More recently, Jelinkova et al. (2019) generated dystrophin-deficient 
human pluripotent stem cell (DMD hPSC) and showed that these 
cells have high levels of ROS, which leads to increased levels of 
ROS-induced DNA damage.
Although, the precise mechanisms and direct or indirect actions 
and targets are not yet clarified, all these studies sustain the 
notion that mutations in the genes encoding ECM components, 
or associated proteins, may trigger oxidative stress and DNA 
damage. Importantly, some studies, especially those focusing on 
muscular dystrophies, have raised the question whether oxidative 
stress constitutes a primary or a secondary event in disease 
progression (Rando, 2002; Moore et  al., 2020). In most cases, 
studies are conducted during the active phase of the disease, 
making it impossible to distinguish between these two events. 
Thus, in the context of mutations in genes encoding ECM 
components or proteins that link the ECM to cytoskeleton, it is 
unclear whether oxidative stress acts as a cause, a consequence 
or both, of disease progression. Hence, more studies are needed 
to fully understand how oxidative stress contributes to each phase 
of the disease. Taking into account the link between oxidative 
stress and DNA damage, it is likely that oxidative stress induced 
DNA damage may not be  limited to DMD (Robbins et  al., 1984; 
Rodriguez and Tarnopolsky, 2003; Jelinkova et  al., 2019), but 
may also be  a feature of the other diseases discussed here. The 
concomitant presence of oxidative stress and DNA damage can 
act as an important driving force for disease progression. Therefore, 
understanding the exact mechanisms behind the accumulation 
of oxidative stress in each phase of these diseases and determining 
the cellular consequences of increased ROS in every phase is 
crucial to design targeted therapies for these devastating conditions.
DISCUSSION
The ECM is an intricate network of different molecules that 
communicate directly to the intracellular space through cell 
surface receptors and downstream signaling cascades. It is 
becoming increasingly clear that altered expression of one of 
these molecules may perturb this fine-tuned communication, 
triggering a domino effect, which severely compromises tissue 
integrity. In this review, we  examined several examples, where 
increased oxidative stress and DNA damage alter the expression 
of genes encoding key ECM components, and conversely, where 
mutations in genes encoding some of the best studied ECM 
glycoproteins and proteins linking the ECM to the cell 
cytoskeleton elicit an increase in oxidative stress and DNA 
damage. The crosstalk between these two processes, and their 
major impact on tissue integrity and function, highlights the 
necessity to study the molecular nature of this relationship 
further, opening the possibility of identifying new candidate 
pathways as targets for therapy.
In response to oxidative stress and DNA damage, regulation 
of ECM remodeling may occur at different levels, including 
(i) transcriptional, via modulation of different transcription 
factors, (ii) posttranslational, by the action of MMPs, TIMPs, 
and LOX, which control the degradation of ECM components, 
and (iii) at the network level, where changes in an ECM 
components or molecules that bridge the ECM to the cell 
cytoskeleton, may trigger a chain reaction that can compromise 
tissue integrity. Here, we discuss how oxidative stress and DNA 
damage could influence or be  influenced by the expression of 
genes encoding ECM components or proteins linking to the 
cell cytoskeleton and dissect out which pathways may be required 
for this regulation.
TGF-β signaling is one of the key regulators of ECM production 
(Hinz, 2015; Tu and Quan, 2016), via the activation of Smad 
transcription factors, which regulate the transcription of ECM 
genes (Figure  3A), for example, collagens and fibronectin, but 
also ECM proteolytic enzymes, such as MMPs (Tu and Quan, 
2016). In particular, induction of TGF-β signaling by oxidative 
stress has been associated with increased transcription of collagens 
and fibronectin (Iglesias-De La Cruz et  al., 2001; Zhao et  al., 
2008; Krstić et  al., 2015; Tu and Quan, 2016). Another study, 
points to the activation of the TNF pathway as important for 
the transcription of collagen I  and III genes, in response to 
angiotensin II-induced oxidative stress (Sriramula and Francis, 
2015), possibly via the activation of the NF-κβ transcription factor 
(Morgan and Liu, 2011). NF-κβ is also activated in response to 
DNA damage (Janssens and Tschopp, 2006), leading to the 
transcription of several targets, including ECM related genes 
(Janssens and Tschopp, 2006; Guo et al., 2021; Figure 3A). NRF2 
is another important orchestrator of the oxidative stress response 
and which acts as a transcription factor (He et  al., 2020). This 
important stress sensor has been shown to be  required for the 
transcriptional regulation of several matrisome genes, including 
collagen I, III, and laminin α1 chain genes (Hiebert et  al., 2018; 
Hiebert, 2021), raising the possibility that in the presence of 
oxidative stress, NRF2 may control ECM remodeling (Figure 3A). 
As mentioned above, the transcriptional regulation of ECM 
components may also be  mediated directly or indirectly via the 
transcription factors p53 and p73, both playing important roles 
sensing oxidative stress and DNA damage (Holmstrom et  al., 
2014; Pflaum et  al., 2014; Williams and Schumacher, 2016; 
Figure 3A). Whether these candidate pathways and transcription 
factors, known to regulate the expression of ECM genes, act in 
a tissue or disease specific manner, remains to be further explored.
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FIGURE 3 | Oxidative stress and DNA damage links to ECM remodeling. (A) Oxidative stress and DNA damage may trigger ECM remodeling by different 
mechanisms. One possible mechanism is associated with ROS-mediated release of TGFβ from the large latent complex, allowing it to bind to the TGFβ receptor (1). 
This promotes the activation of the SMAD transcriptional complex, known to promote transcription of ECM genes. Another possible mechanism involves the activation 
of the NF-κβ transcription factor (2). This may occur in the presence of oxidative stress leading to NF-κβ mediated transcription of TNFα, which in turn further 
promotes NF-κβ activation and transcriptional regulation of ECM genes. NF-κβ can also be activated by DNA damage and control the transcription of ECM target 
genes. The oxidative stress sensor nuclear factor erythroid 2-related factor 2 (NRF2; 3), may also have a crucial role in the transcriptional regulation of ECM genes. 
The transcription factors p53 and p73, which regulate ECM gene expression, are both known targets of oxidative stress and DNA damage (4). (B) ECM stability is 
important to prevent the generation of oxidative stress and DNA damage. The integrin-focal adhesion kinase (FAK) pathway promotes mitochondrial function, via 
(Continued)
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As detailed earlier, several studies point to oxidative stress 
and DNA damage being a consequence, rather than a cause, of 
changes in the ECM. In line with this, mutations in genes encoding 
ECM components or molecules that bridge the ECM to the cell 
cytoskeleton have been described to lead to mitochondrial 
dysfunction (Irwin et  al., 2003; Millay et  al., 2008; Shkryl et  al., 
2009; Menazza et  al., 2010; de Oliveira et  al., 2014; Sorato et  al., 
2014; Fontes-Oliveira et al., 2017; Gremminger et al., 2019; Kölbel 
et  al., 2019), a driving force for ROS accumulation. There are 
several different mechanisms that can explain why mitochondria 
may function as an important sensor for ECM changes (De 
Cavanagh et al., 2009), and therefore, why mitochondrial dysfunction 
is a hallmark of muscular dystrophies (Cantó-Santos et al., 2020). 
ECM glycoproteins, including laminins and fibronectin, have been 
shown to promote mitochondrial function via integrin-focal 
adhesion kinase (FAK) signaling, which culminates in the 
translocation of phosphorylated STAT3 to the mitochondria 
(Visavadiya et  al., 2016; Figure  3B). Other possible mechanisms 
are related to the loss of adhesion to the ECM, which changes 
the cellular uptake of nutrients, namely glucose (Schafer et  al., 
2009; Eble and De Rezende, 2014). These effects together with 
the reduction in the activity of phosphatidyl-inositol-3-kinase 
(PI3K) and Akt, also associated with altered ECM composition, 
elicits dramatic metabolic changes including decreased activity 
of the pentose phosphate pathway, which represents an important 
source of NADPH, a powerful antioxidant molecule (Eble and 
De Rezende, 2014; Figure 3B). In addition to signaling pathways 
linking ECM to mitochondria, biomechanical properties of the 
ECM, such as stiffness (i.e., how rigid the ECM structure is), 
can impact mitochondrial function (Chen et al., 2021; Figure 3B). 
High ECM stiffness has been shown to promote mitochondrial 
fusion and suppress mitochondrial fission downstream of integrin 
signaling (Chen et al., 2021). The importance of ECM biomechanical 
properties goes beyond maintaining mitochondrial stability. Low 
ECM stiffness compromises the DNA damage response, making 
cells more sensitive to DNA damaging agents (Deng et al., 2020), 
while high ECM stiffness promotes nuclear rupture also leading 
to increased DNA damage (Cho et al., 2019; Figure 3B). Altogether, 
these studies suggest that countering mitochondrial dysfunction, 
and possibly preventing DNA damage, may be a promising strategy 
to revert the pathology caused by some mutations in genes 
encoding ECM components, their receptors or molecules that 
bridge ECM receptors to the cell cytoskeleton.
In conclusion, future studies are needed to characterize all 
the players and intermediates involved in the link between 
oxidative stress/DNA damage and ECM remodeling. Only with 
this increased knowledge can new candidate pathways and 
targets be  identified. This will be  instrumental to establish 
novel lines of therapy, for diseases where ROS and DNA damage 
drive ECM remodeling, or where mutations in ECM-related 
genes elicit an over-accumulation of ROS and DNA damage.
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